Hubid, Rolly .
HRN: 12-34-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
CEFTRIAXONE 1G (VIAL)
08/27/2023
09/02/2023
IV
2g
OD
Cap Mr/ SBP
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes